Table 1.
The MICs of key antibiotics for SHV-12 producing E. aerogenes (EaN146), the transformant (TFN146) and the SHV-12 producing clone (CN146)
| Aba | μg/ml | ||
|---|---|---|---|
| EaN146 | TFN146 | CN146 | |
| Ampicillin | ≥256 | ≥256 | ≥256 |
| Ampicillin/Clav | ≥256 | 64 | 32 |
| Cefepime | 16 | 0,5 | 128 |
| Cefepime/Clav | 0,025 | 0,025 | 0,025 |
| Ceftazidime | 128 | 0,5 | ≥256 |
| Ceftazidime/Clav | 64 | 0,5 | 4 |
| Cefotaxime | 16 | <1 | >256 |
| Piperacillin | 32 | >128 | >128 |
| Piperacillin/Tazo | <4 | <4 | >128 |
| Imipenem | <1 | <1 | <1 |
| Meropenem | <0.25 | <0.25 | <0.25 |
| Ciprofloxacin | <0.25 | <0.25 | <0.25 |
| Gentamicin | >16 | <1 | <1 |
| Tobramycin | 8 | <1 | <1 |
aClav, clavulanate (4 μg/ml), Tazo, tazobactam (8 μg/ml)